← FDA DRUG APPROVALS

FDA ANDA · ANDA084887

CHLORDIAZEPOXIDE HYDROCHLORIDE

Sponsor: MYLAN

APPLICATION
ANDA084887
TYPE
ANDA
LATEST ACTION
1981-06-10
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CHLORDIAZEPOXIDE HYDROCHLORIDEDiscontinued
CHLORDIAZEPOXIDE HYDROCHLORIDE 25MG · CAPSULE · ORAL

Approval history

1981-06-10Manufacturing (CMC) · Supplement 56AP
1981-06-10Manufacturing (CMC) · Supplement 57AP
1981-06-10Manufacturing (CMC) · Supplement 55AP
1981-06-10Manufacturing (CMC) · Supplement 58AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →